{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:43:38Z","timestamp":1782787418913,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research Project of Sichuan Anti-Cancer Association Clinical Research","award":["XH2023 5008"],"award-info":[{"award-number":["XH2023 5008"]}]},{"name":"Sichuan Medical Science & Technology Innovation Research Association","award":["YCH-KY-YCZD2024-106"],"award-info":[{"award-number":["YCH-KY-YCZD2024-106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05018-5","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:13:27Z","timestamp":1778051607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early mortality in multiple myeloma patients with renal impairment: a nested case-control study"],"prefix":"10.1186","volume":"27","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"6","key":"5018_CR1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111(6):2962\u201372.","journal-title":"Blood"},{"issue":"5","key":"5018_CR2","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111(5):2516\u201320.","journal-title":"Blood"},{"issue":"22","key":"5018_CR3","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1158\/1078-0432.CCR-16-0625","volume":"22","author":"KC Anderson","year":"2016","unstructured":"Anderson KC. Progress and Paradigms in Multiple Myeloma. Clin Cancer Res. 2016;22(22):5419\u201327.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5018_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-023-01474-w","volume":"16","author":"N Lopez-Munoz","year":"2023","unstructured":"Lopez-Munoz N, Hernandez-Ibarburu G, Alonso R, Sanchez-Pina JM, Ayala R, Calbacho M, Cuellar C, Cedena MT, Jimenez-Ubieto A, Iniguez R, et al. Large-scale real-life analysis of survival and usage of therapies in multiple myeloma. J Hematol Oncol. 2023;16(1):76.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5018_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41408-025-01253-5","volume":"15","author":"JTD Souto Filho","year":"2025","unstructured":"Souto Filho JTD, Cantadori LO, Crusoe EQ, Hungria V, Maiolino A. Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis. Blood Cancer J. 2025;15(1):37.","journal-title":"Blood Cancer J"},{"issue":"36","key":"5018_CR6","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","volume":"23","author":"BM Augustson","year":"2005","unstructured":"Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, Behrens J, Smith A, Child JA, Drayson MT. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002\u2013Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23(36):9219\u201326.","journal-title":"J Clin Oncol"},{"issue":"5","key":"5018_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28(5):1122\u20138.","journal-title":"Leukemia"},{"issue":"7","key":"5018_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/10245332.2015.1101969","volume":"21","author":"YK Chen","year":"2016","unstructured":"Chen YK, Han SM, Yang Y, Lin TH, Tzeng HE, Chang KH, Hwang WL, Teng CL. Early mortality in multiple myeloma: Experiences from a single institution. Hematology. 2016;21(7):392\u20138.","journal-title":"Hematology"},{"issue":"8","key":"5018_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s002770100330","volume":"80","author":"H Murakami","year":"2001","unstructured":"Murakami H, Hayashi K, Hatsumi N, Saitoh T, Yokohama A, Matsushima T, Tsukamoto N, Morita K, Karasawa M, Ogawara H, et al. Risk factors for early death in patients undergoing treatment for multiple myeloma. Ann Hematol. 2001;80(8):452\u20135.","journal-title":"Ann Hematol"},{"issue":"11","key":"5018_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41408-021-00571-8","volume":"11","author":"M Brink","year":"2021","unstructured":"Brink M, Groen K, Sonneveld P, Minnema MC, Broijl A, Dinmohamed AG, van der Spek E, Levin MD, Ypma PF, de Waal E, et al. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study. Blood Cancer J. 2021;11(11):178.","journal-title":"Blood Cancer J"},{"issue":"1","key":"5018_CR11","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1002\/ajh.25320","volume":"94","author":"M Galli","year":"2019","unstructured":"Galli M, Paris L, Pavoni C, Delaini F, Rambaldi A. Effect of novel agents on the risk of early death of newly diagnosed symptomatic multiple myeloma patients: A single Centre retrospective analysis. Am J Hematol. 2019;94(1):E11\u20133.","journal-title":"Am J Hematol"},{"issue":"13","key":"5018_CR12","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/cncr.34760","volume":"129","author":"SJ Grant","year":"2023","unstructured":"Grant SJ, Wildes TM, Rosko AE, Silberstein J, Giri S. A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma. Cancer. 2023;129(13):2023\u201334.","journal-title":"Cancer"},{"issue":"6","key":"5018_CR13","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1177\/0300060518757640","volume":"46","author":"J Xia","year":"2018","unstructured":"Xia J, Wang L, Zhou X, Wang J, Wang H, Guo H. Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice. J Int Med Res. 2018;46(6):2230\u20137.","journal-title":"J Int Med Res"},{"issue":"5","key":"5018_CR14","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1016\/j.clml.2020.12.023","volume":"21","author":"V Kumar","year":"2021","unstructured":"Kumar V, Ailawadhi M, Dutta N, Abdulazeez M, Aggarwal CS, Quintero G, Baksh M, Roy V, Sher T, Alegria V, et al. Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis. Clin Lymphoma Myeloma Leuk. 2021;21(5):e449\u201355.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"5018_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ajh.24389","volume":"91","author":"R Rios-Tamayo","year":"2016","unstructured":"Rios-Tamayo R, Sainz J, Martinez-Lopez J, Puerta JM, Chang DY, Rodriguez T, Garrido P, de Veas JL, Romero A, Moratalla L, et al. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients. Am J Hematol. 2016;91(7):700\u20134.","journal-title":"Am J Hematol"},{"issue":"7","key":"5018_CR16","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/S1470-2045(23)00223-1","volume":"24","author":"MA Dimopoulos","year":"2023","unstructured":"Dimopoulos MA, Merlini G, Bridoux F, Leung N, Mikhael J, Harrison SJ, Kastritis E, Garderet L, Gozzetti A, van de Donk N, et al. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group. Lancet Oncol. 2023;24(7):e293\u2013311.","journal-title":"Lancet Oncol"},{"issue":"5","key":"5018_CR17","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/leu.2015.15","volume":"29","author":"R Khan","year":"2015","unstructured":"Khan R, Apewokin S, Grazziutti M, Yaccoby S, Epstein J, van Rhee F, Rosenthal A, Waheed S, Usmani S, Atrash S, et al. Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma. Leukemia. 2015;29(5):1195\u2013201.","journal-title":"Leukemia"},{"issue":"13","key":"5018_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Sonneveld P, Leung N, Merlini G, Ludwig H, Kastritis E, Goldschmidt H, Joshua D, Orlowski RZ, Powles R, et al. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment. J Clin Oncol. 2016;34(13):1544\u201357.","journal-title":"J Clin Oncol"},{"issue":"5","key":"5018_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/leu.2011.3","volume":"25","author":"MA Dimopoulos","year":"2011","unstructured":"Dimopoulos MA, Palumbo A, Attal M, Beksac M, Davies FE, Delforge M, Einsele H, Hajek R, Harousseau JL, da Costa FL, et al. Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia. 2011;25(5):749\u201360.","journal-title":"Leukemia"},{"key":"5018_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12885-016-2645-y","volume":"16","author":"SH Jung","year":"2016","unstructured":"Jung SH, Cho MS, Kim HK, Kim SJ, Kim K, Cheong JW, Kim SJ, Kim JS, Ahn JS, Kim YK, et al. Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen. BMC Cancer. 2016;16:613.","journal-title":"BMC Cancer"},{"issue":"9","key":"5018_CR21","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ajh.24796","volume":"92","author":"H Terebelo","year":"2017","unstructured":"Terebelo H, Srinivasan S, Narang M, Abonour R, Gasparetto C, Toomey K, Hardin JW, Larkins G, Kitali A, Rifkin RM, et al. Recognition of early mortality in multiple myeloma by a prediction matrix. Am J Hematol. 2017;92(9):915\u201323.","journal-title":"Am J Hematol"},{"issue":"2","key":"5018_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000531314","volume":"148","author":"P Delanaye","year":"2024","unstructured":"Delanaye P. H <>Pottel 2024 Estimating Glomerular Filtration Rate in China: Is the European Kidney Function Consortium (EKFC) Equation the Solution? Nephron 148 2 74\u20137.","journal-title":"Nephron"},{"key":"5018_CR23","doi-asserted-by":"publisher","first-page":"1566011","DOI":"10.3389\/fendo.2025.1566011","volume":"16","author":"S Gao","year":"2025","unstructured":"Gao S, Liu Y, Liu H, Lin Y, Bai P, Hou F, Lu S, Zhou S, Sun H, Ma G, et al. Association between obesity indexes and chronic kidney disease risk: a double-cohort prospective study in the Binhai and UK Biobank. Front Endocrinol (Lausanne). 2025;16:1566011.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"5018_CR24","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u2013548.","journal-title":"Lancet Oncol"},{"issue":"4","key":"5018_CR25","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1002\/ajh.23932","volume":"90","author":"MO Holmstrom","year":"2015","unstructured":"Holmstrom MO, Gimsing P, Abildgaard N, Andersen NF, Helleberg C, Clausen NA, Klausen TW, Frederiksen M, Kristensen DL, Larsen H, et al. Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database. Am J Hematol. 2015;90(4):E73\u201374.","journal-title":"Am J Hematol"},{"key":"5018_CR26","doi-asserted-by":"crossref","unstructured":"Kumar SK, Callander NS, Adekola K, Anderson LD Jr., Baljevic M, Baz R, Campagnaro E, Costello C, D\u2019Angelo C, Derman B, et al. Multiple myeloma, version 5.2026: NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2026;24(1).","DOI":"10.6004\/jnccn.2026.0001"},{"issue":"25","key":"5018_CR27","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1161\/01.CIR.102.25.3074","volume":"102","author":"S Wiese","year":"2000","unstructured":"Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, Fuchtbauer EM, Dohrmann U, Beyersdorf F, Radicke D, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation. 2000;102(25):3074\u20139.","journal-title":"Circulation"},{"issue":"1","key":"5018_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2310\/JIM.0b013e318194f44b","volume":"57","author":"N Khalifeh","year":"2009","unstructured":"Khalifeh N, Haider D, Horl WH. Natriuretic peptides in chronic kidney disease and during renal replacement therapy: an update. J Investig Med. 2009;57(1):33\u20139.","journal-title":"J Investig Med"},{"issue":"11","key":"5018_CR29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/ajh.24532","volume":"91","author":"P Milani","year":"2016","unstructured":"Milani P, Vincent Rajkumar S, Merlini G, Kumar S, Gertz MA, Palladini G, Lacy MQ, Buadi FK, Hayman SR, Leung N, et al. N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma. Am J Hematol. 2016;91(11):1129\u201334.","journal-title":"Am J Hematol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05018-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:45:06Z","timestamp":1782783906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05018-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5018"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05018-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8507723\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Review Committee of West China Hospital, Sichuan University, with the need for written informed consent waived. All methods used in this study follow the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}